These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 10352283)

  • 41. Genetic control of natural killing and in vivo tumor elimination by the Chok locus.
    Idris AH; Iizuka K; Smith HR; Scalzo AA; Yokoyama WM
    J Exp Med; 1998 Dec; 188(12):2243-56. PubMed ID: 9858511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lysis of tumor cells by natural killer cells in mice is impeded by platelets.
    Nieswandt B; Hafner M; Echtenacher B; Männel DN
    Cancer Res; 1999 Mar; 59(6):1295-300. PubMed ID: 10096562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum.
    Smyth MJ; Kelly JM; Baxter AG; Körner H; Sedgwick JD
    J Exp Med; 1998 Nov; 188(9):1611-9. PubMed ID: 9802973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lysis of a lung carcinoma by poly I:C-induced natural killer cells is independent of the expression of class I histocompatibility antigens.
    Dennert G; Landon C; Lord EM; Bahler DW; Frelinger JG
    J Immunol; 1988 Apr; 140(7):2472-5. PubMed ID: 3351305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Morphologic and functional characterization of perforin-deficient lymphokine-activated killer cells.
    Liu CC; Walsh CM; Eto N; Clark WR; Young JD
    J Immunol; 1995 Jul; 155(2):602-8. PubMed ID: 7608538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phenotypic and functional characterization of a panel of cytotoxic murine NK cell clones that are heterogeneous in their enhancement of Ig secretion in vitro.
    Vos Q; Ortaldo JR; Conan-Cibotti M; Vos MD; Young HA; Anderson SK; Witherspoon K; Prager I; Snapper CM; Mond JJ
    Int Immunol; 1998 Aug; 10(8):1093-101. PubMed ID: 9723695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent.
    Smyth MJ; Taniguchi M; Street SE
    J Immunol; 2000 Sep; 165(5):2665-70. PubMed ID: 10946296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor immunity in perforin-deficient mice: a role for CD95 (Fas/APO-1).
    Rosen D; Li JH; Keidar S; Markon I; Orda R; Berke G
    J Immunol; 2000 Mar; 164(6):3229-35. PubMed ID: 10706715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
    Rivera LM; Lopez DM
    Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor protection by IL-7 secreting whole cell vaccine is merely mediated by NK1.1-positive cells.
    Schroten C; Scheffer R; Boon L; de Ridder CM; Bangma CH; Kraaij R
    J Immunother; 2012; 35(2):125-30. PubMed ID: 22306900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.
    Street SE; Cretney E; Smyth MJ
    Blood; 2001 Jan; 97(1):192-7. PubMed ID: 11133760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on natural killer (NK) cells. III. The effects of in vitro culture on spontaneous cytotoxicity of murine spleen cells.
    Bartlett SP; Burton RC
    J Immunol; 1982 Mar; 128(3):1070-5. PubMed ID: 7057032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An improved method to study NK-independent mechanisms of MTLn3 breast cancer lung metastasis.
    van Nimwegen MJ; Verkoeijen S; Kuppen PJ; Velthuis JH; van de Water B
    Clin Exp Metastasis; 2007; 24(5):379-87. PubMed ID: 17541710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege.
    Apte RS; Sinha D; Mayhew E; Wistow GJ; Niederkorn JY
    J Immunol; 1998 Jun; 160(12):5693-6. PubMed ID: 9637476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreased tumor surveillance in perforin-deficient mice.
    van den Broek ME; Kägi D; Ossendorp F; Toes R; Vamvakas S; Lutz WK; Melief CJ; Zinkernagel RM; Hengartner H
    J Exp Med; 1996 Nov; 184(5):1781-90. PubMed ID: 8920866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adhesion mediated by LFA-1 is required for efficient IL-12-induced NK and NKT cell cytotoxicity.
    Matsumoto G; Omi Y; Lee U; Nishimura T; Shindo J; Penninger JM
    Eur J Immunol; 2000 Dec; 30(12):3723-31. PubMed ID: 11169416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Fas/Fas ligand pathway is important for optimal tumor regression in a mouse model of CTL adoptive immunotherapy of experimental CMS4 lung metastases.
    Caldwell SA; Ryan MH; McDuffie E; Abrams SI
    J Immunol; 2003 Sep; 171(5):2402-12. PubMed ID: 12928387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
    Hayakawa Y; Kelly JM; Westwood JA; Darcy PK; Diefenbach A; Raulet D; Smyth MJ
    J Immunol; 2002 Nov; 169(10):5377-81. PubMed ID: 12421908
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of a novel monoclonal antibody against human perforin using transfected cell lines.
    Schlesinger BC; Cheng L
    Immunology; 1994 Feb; 81(2):291-5. PubMed ID: 8157278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.